Background:Ginkgo biloba extract EGb 761? is widely used to treat various types of vertigo. Aims: An exploratory trial was conducted to evaluate the efficacy of EGb 761? in addition to vestibular exercises in central vestibular vertigo caused by vertebro-basilar ischaemia. Subjects and Methods: In this randomised, placebo-controlled, double-blind trial, 40 patients were enrolled in the vertigo clinic of a neurological university hospital and treated with daily doses of 240 mg EGb 761? or placebo for a period of 180 days. All patients regularly performed vestibular exercises in addition. Efficacy was assessed using: a visual analogue scale for the patients to rate the overall intensity of vertigo; a numeric scale for physician-rated change; a vertigo score based on intensity, duration, and frequency of vertigo; and electronystagmography. Results: Until day 180, the mean patient-rated intensity of vertigo decreased by 46% during EGb 761? treatment and by 19% with placebo (p < 0.05 for between-group difference). The vertigo score decreased at a significantly greater rate in the EGb 761? group compared to the placebo group. Nystagmus or other eye movement disorders were present only in small subgroups of patients without sufficient statistical power to detect differences between treatment groups. Conclusions: EGb 761? alleviated vertigo caused by ischaemic lesions in the brainstem or cerebellum in patients undergoing vestibular exercises.
References
[1]
Strupp, M., Dlugaiczyk, J., Ertl-Wagner, B.B., Rujescu, D., Westhofen, M. and Dieterich, M. (2020) Vestibular Disorders: Diagnosis, New Classification and Treatment. Deutsches Ärzteblatt International, 117, 300-310. https://doi.org/10.3238/arztebl.2020.0300
[2]
Mohwald, K., Hadzhikolev, H., Bardins, S., Becker-Bense, S., Brandt, T., Grill, E., Jahn, K., Dieterich, M. and Zwergal, A. (2020) Health-Related Quality of Life and Functional Impairment in Acute Vestibular Disorders. European Journal of Neurology, 27, 2089-2098. https://doi.org/10.1111/ene.14318
[3]
Neuhauser, H.K. (2016) The Epidemiology of Dizziness and Vertigo. The Handbook of Clinical Neurology, 137, 67-82. https://doi.org/10.1016/B978-0-444-63437-5.00005-4
[4]
Lin, H.W. and Bhattacharyya, N. (2014) Impact of Dizziness and Obesity on the Prevalence of Falls and Fall-Related Injuries. Laryngoscope, 124, 2797-2801. https://doi.org/10.1002/lary.24806
[5]
Ward, B.K., Agrawal, Y., Hoffman, H.J., Carey, J.P. and Della Santina, C.C. (2013) Prevalence and Impact of Bilateral Vestibular Hypofunction: Results from the 2008 US National Health Interview Survey. JAMA Otolaryngology—Head & Neck Surgery, 139, 803-810. https://doi.org/10.1001/jamaoto.2013.3913
[6]
Gauthier, S. and Schlaefke, S. (2014) Efficacy and Tolerability of Ginkgo biloba Extract EGb 761® in Dementia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Clinical Interventions in Aging, 9, 2065-2077. https://doi.org/10.2147/CIA.S72728
[7]
Grass-Kapanke, B., Busmane, A., Lasmanis, A., Hoerr, R. and Kaschel, R. (2011) Effects of Ginkgo biloba Special Extract EGb 761® in Very Mild Cognitive Impairment (vMCI). Neuroscience and Medicine, 2, 48-56. https://doi.org/10.4236/nm.2011.21007
[8]
Gavrilova, S.I., Preuss, U.W., Wong, J.W., Hoerr, R., Kaschel, R. and Bachinskaya, N. (2014) Efficacy and Safety of Ginkgo biloba Extract EGb(R) 761 in Mild Cognitive Impairment with Neuropsychiatric Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Trial. International Journal of Geriatric Psychiatry, 29, 1087-1095. https://doi.org/10.1002/gps.4103
[9]
Tan, M.S., Yu, J.T., Tan, C.C., Wang, H.F., Meng, X.F., Wang, C., Jiang, T., Zhu, X.C. and Tan, L. (2015) Efficacy and Adverse Effects of Ginkgo biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease, 43, 589-603. https://doi.org/10.3233/JAD-140837
[10]
Hashiguchi, M., Ohta, Y., Shimizu, M., Maruyama, J. and Mochizuki, M. (2015) Meta-Analysis of the Efficacy and Safety of Ginkgo biloba Extract for the Treatment of Dementia. Journal of Pharmaceutical Health Care and Sciences, 1, Article No. 14. https://doi.org/10.1186/s40780-015-0014-7
[11]
Hallak, B., Schneider, A., Güntensperger, D. and Schapowal, A. (2021) Standardized Ginkgo biloba Extract in the Treatment of Vertigo and/or Tinnitus: A Review of the Literature. Advances in Aging Research, 10, 31-57. https://doi.org/10.4236/aar.2021.102002
[12]
Lindner, M., Gosewisch, A., Eilles, E., Branner, C., Kramer, A., Oos, R., Wolf, E., Ziegler, S., Bartenstein, P., Brandt, T., Dieterich, M. and Zwergal, A. (2019) Ginkgo biloba Extract EGb 761 Improves Vestibular Compensation and Modulates Cerebral Vestibular Networks in the Rat. Frontiers in Neurology, 10, Article No. 147. https://doi.org/10.3389/fneur.2019.00147
[13]
Müller, W.E., Heiser, J. and Leuner, K. (2012) Effects of the Standardized Ginkgo biloba Extract EGb 761® on Neuroplasticity. International Psychogeriatrics, 24, S21-S24. https://doi.org/10.1017/S1041610212000592
[14]
Tighilet, B. and Lacour, M. (1995) Pharmacological Activity of the Ginkgo biloba Extract (EGb 761) on Equilibrium Function Recovery in the Unilateral Vestibular Neurectomized Cat. Journal of Vestibular Research, 5, 187-200. https://doi.org/10.3233/VES-1995-5303
[15]
Haguenauer, J.P., Koskas C.F. and Pierart, H. (1986) Treatment of Disturbances of Equilibrium with Ginkgo biloba Extract. A Multicentered Placebo-Controlled Double-Blind Study. La Presse Médicale, 15, 1569-1572.
[16]
Hamann, K.F. (2007) Ginkgo-Spezialextrakt bei Schwindel: Ein systematischer Review randomisierter, doppelblinder, placebokontrollierter klinischer Prüfungen. [Special Ginkgo Extract in Cases of Vertigo: A Systematic Review of Randomised, Double-Blind, Placebo Controlled Clinical Examinations]. HNO, 55, 258-263. https://doi.org/10.1007/s00106-006-1440-5
[17]
Dunlap, P.M., Holmberg, J.M. and Whitney, S.L. (2019) Vestibular Rehabilitation: Advances in Peripheral and Central Vestibular Disorders. Current Opinion in Neurology, 32, 137-144. https://doi.org/10.1097/WCO.0000000000000632
[18]
Strupp, M., Arbusow, V., Maag, K.P., Gall, C. and Brandt, T. (1998) Vestibular Exercises Improve Central Vestibulospinal Compensation after Vestibular Neuritis. Neurology, 51, 838-844. https://doi.org/10.1212/WNL.51.3.838
[19]
Yardley, L., Masson, E., Verschuur, C., Haacke, N. and Luxon, L. (1992) Symptoms, Anxiety and Handicap in Dizzy Patients: Development of the Vertigo Symptom Scale. Journal of Psychosomatic Research, 36, 731-741. https://doi.org/10.1016/0022-3999(92)90131-K
[20]
Axer, H., Finn, S., Wassermann, A., Guntinas-Lichius, O., Klingner, C.M. and Witte, O.W. (2020) Multimodal Treatment of Persistent Postural-Perceptual Dizziness. Brain and Behavior, 10, e01864. https://doi.org/10.1002/brb3.1864
[21]
Ahlemeyer, B. and Krieglstein, J. (2003) Neuroprotective Effects of Ginkgo biloba Extract. Cellular and Molecular Life Sciences, 60, 1779-1792. https://doi.org/10.1007/s00018-003-3080-1
[22]
Muller, W.E., Eckert, A., Eckert, G.P., Fink, H., Friedland, K., Gauthier, S., Hoerr, R., Ihl, R., Kasper, S. and Moller, H.J. (2019) Therapeutic Efficacy of the Ginkgo Special Extract EGb761((R)) within the Framework of the Mitochondrial Cascade Hypothesis of Alzheimer’s Disease. The World Journal of Biological Psychiatry, 20, 173-189. https://doi.org/10.1080/15622975.2017.1308552
[23]
Perez, N., Martin, E. and Garcia-Tapia, R. (2003) Dizziness: Relating the Severity of Vertigo to the Degree of Handicap by Measuring Vestibular Impairment. Otolaryngology—Head and Neck Surgery, 128, 372-381. https://doi.org/10.1067/mhn.2003.102
[24]
Strupp, M., Teufel, J., Habs, M., Feuerecker, R., Muth, C., van de Warrenburg, B.P., Klopstock, T. and Feil, K. (2013) Effects of Acetyl-DL-leucine in Patients with Cerebellar Ataxia: A Case Series. Journal of Neurology, 260, 2556-2561. https://doi.org/10.1007/s00415-013-7016-x
[25]
Hamann, K.-F. (1985) Physikalische Therapie des vestibulären Schwindels in Verbindung mit Ginkgo-biloba-Extrakt. Therapiewoche, 35, 4586-4590.
[26]
Cesarani, A., Meloni, F., Alpini, D., Barozzi, S., Verderio, L. and Boscani, P.F. (1998) Ginkgo biloba (EGb 761) in the Treatment of Equilibrium Disorders. Advances in Therapy, 15, 291-304.
[27]
Claussen, C.F. and Kirtane, M.V. (1985) Randomisierte Doppelblindstudie zur Wirkung von Extractum Ginkgo biloba bei Schwindel und Gangunsicherheit des älteren Menschen. In: Claussen, C.-F., Ed., Presbyvertigo Presbyataxie Presbytinnitus, Springer, Berlin, 103-115. https://doi.org/10.1007/978-3-642-70035-4_4
[28]
Sokolova, L., Hoerr, R. and Mishchenko, T. (2014) Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine. International Journal of Otolaryngology, 2014, Article ID: 682439. https://doi.org/10.1155/2014/682439
[29]
Spiegel, R., Kalla, R., Mantokoudis, G., Maire, R., Mueller, H., Hoerr, R. and Ihl, R. (2018) Ginkgo biloba Extract EGb 761® Alleviates Neurosensory Symptoms in Patients with Dementia: A Meta-Analysis of Treatment Effects on Tinnitus and Dizziness in Randomized, Placebo-Controlled Trials. Clinical Interventions in Aging, 13, 1121-1127. https://doi.org/10.2147/CIA.S157877
[30]
Zwergal, A., Strupp, M. and Brandt, T. (2019) Advances in Pharmacotherapy of Vestibular and Ocular Motor Disorders. Expert Opinion on Pharmacotherapy, 20, 1267-1276. https://doi.org/10.1080/14656566.2019.1610386
